The landscape of genetic alterations in HCC has a clear delineation, including the most prevalent mutations affecting TERT promoter (60%) [5], TP53 (12–48%) [6–8], and CTNNB1 (11–37%) [9]. This evidence concerns the gene TP53 and hepatocellular carcinoma.